These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1533738)

  • 1. [New, in Austria registered specialty drugs. Inhibace (cilazapril)].
    Töglhofer W
    Wien Klin Wochenschr; 1992; 104(6):178-82. PubMed ID: 1533738
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
    Sánchez RA; Traballi CA; Barclay CA; Gilbert HB; Muscará M; Giannone C; Moledo LI
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cilazapril in essential hypertension. A study of one year of continuous treatment].
    Lange H; Belz GG; Tschollar W; Wolf GK
    Med Klin (Munich); 1988 Sep; 83(17):554-8. PubMed ID: 2971866
    [No Abstract]   [Full Text] [Related]  

  • 4. Antihypertensive treatment with cilazapril. Resting and exercise blood pressure, hormones and enzymes.
    Breithaupt K; Belz GG; Spielmanns DG; Neis W; Kirchner P
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):136-41. PubMed ID: 2159308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular protection with cilazapril in hypertension.
    Clozel JP; Kuhn H; Hefti F
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S28-33. PubMed ID: 1381792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilazapril. A review.
    Szucs T
    Drugs; 1991; 41 Suppl 1():18-24. PubMed ID: 1712267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal and impaired renal function.
    Shionoiri H; Gotoh E; Takagi N; Takeda K; Yabana M; Kaneko Y
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):242-9. PubMed ID: 2452321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cilazapril, a new ACE inhibitor, in severe arterial hypertension].
    Arcila Herrera H; Montero Cervantes L; Rivero Cárdenas NA; Osorio Guerreo MI; Flores Serrano AG; González Franco MF
    Arch Inst Cardiol Mex; 1991; 61(6):573-8. PubMed ID: 1838916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilazapril: a new non-thiol-containing angiotensin-converting enzyme inhibitor. Worldwide clinical experience in hypertension.
    Kögler P
    Am J Med; 1989 Dec; 87(6B):50S-55S. PubMed ID: 2532461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving role of angiotensin-converting enzyme inhibitors in cardiovascular therapy. Second International Symposium on Cilazapril. February 9 to 11, 1989, Basel, Switzerland. Proceedings.
    Am J Med; 1989 Dec; 87(6B):1S-99S. PubMed ID: 2532456
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension.
    Clozel JP; Kuhn H; Hefti F
    J Hypertens; 1989 Apr; 7(4):267-75. PubMed ID: 2524524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease.
    Deget F; Brogden RN
    Drugs; 1991 May; 41(5):799-820. PubMed ID: 1712710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers and ACE-inhibitors--further evidence for therapeutic benefit of this combination in hypertension.
    Erb KA; Breithaupt K; Belz GG
    J Hum Hypertens; 1990 Feb; 4(1):63. PubMed ID: 1971655
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of cilazapril, a new angiotensin-converting enzyme inhibitor.
    Goldszer RC; Rodriguez R; Solomon HS
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):300S-302S. PubMed ID: 2970856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the angiotensin converting enzyme inhibitor cilazapril, the beta-blocker propranolol and their combination on haemodynamics in hypertension.
    Belz GG; Breithaupt K; Erb K; Kleinbloesem CH; Wolf GK
    J Hypertens; 1989 Oct; 7(10):817-24. PubMed ID: 2531184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular angiotensin converting enzyme activity in spontaneously hypertensive rats and its inhibition with cilazapril.
    Nakamura Y; Nakamura K; Matsukura T; Nakamura K
    J Hypertens; 1988 Feb; 6(2):105-10. PubMed ID: 2832472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-finding study of cilazapril (Inhibace) in patients with uncomplicated essential hypertension.
    Mroczek WJ; Klein J; Burris JF
    Clin Exp Hypertens A; 1991; 13(8):1415-32. PubMed ID: 1836986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to the actions of atrial natriuretic factor in insulin-dependent diabetic hypertensives and improvement with angiotensin converting enzyme inhibitor treatment.
    Fioretto P; Muollo B; Ben GP; Mollo F; Frigato F; Opocher G; Trevisan R; Carraro A; Sambataro M; Nosadini R
    J Hypertens Suppl; 1991 Dec; 9(6):S262-3. PubMed ID: 1840196
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular protection with cilazapril.
    Clozel JP; Powell JS; Kuhn H; Müller RK; Hefti F; Baumgartner HR
    Drugs; 1991; 41 Suppl 1():62-7. PubMed ID: 1712274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and effects on renal function following cilazapril and hydrochlorothiazide alone and in combination in healthy subjects and hypertensive patients.
    Nilsen OG; Sellevold OF; Romfo OS; Smedsrud A; Grynne B; Williams PE; Kleinbloesem CH
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):323S-328S. PubMed ID: 2527546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.